Seminal
The magazine and atlas of EU-funded researchA new publication from the web and AI team at Scott Charnley

Atlas / United Kingdom

Marie Skłodowska-Curie Action · Running

Electro-Nervogel Multifunctional Electromagnetic Injectable Hydrogel for Treating Osteochondral Defect Via Neurostimulated Bone Regeneration

Coordinator
The Royal Veterinary College, United Kingdom
Runs
1 August 2026 to 31 July 2029
Status
Running
EU funding
€454k
Total cost
—
Partners
2 organisations in 2 countries
Type
Marie Skłodowska-Curie Action
Grant agreement
101277944

What the project is doing

In the project's own words, from its summary on CORDIS.

The deep osteochondral defects affect millions of people worldwide and remain a challenge for orthopaedic surgeons. It causes a major impact on quality of life, affecting mobility, and poses a major economic burden on the healthcare system. The increasing demand for knee grafts is reflected in the growing market size. The available clinical strategies include surgical methods such as knee grafts, scaffolds of stem cells, and growth factors.

However, these suffer from challenges of rejection, high cost, incomplete tissue formation, and provide short-term relief. Traditional biomaterials fail to mimic the bone-cartilage interface, exhibit poor tissue integration, lack signals to recruit cells, and don’t address disease progression and nerve signalling. Electromagnetic (EM) stimulation is a biologically free approach that restores the electrophysiology via neuromodulation for effective tissue repair.

However, EM use is limited to toxic biomaterials, painful implantation, and low clinical efficacy at the site. Hence, there is an unmet need for an ideal biomaterial to solve these challenges. The Electro-Nervogel addresses these challenges and advances the field of bone-neuro engineering by developing and testing the safety and efficacy of a multifunctional, minimally invasive injectable hydrogel for osteochondral repair via neuromodulation.

The project incorporates biodegradable and sustainable principles into biomaterial science, in line with the European mission Horizon 2020 of the European Green Deal and the UN Decade of healthy ageing. The Global Fellowship will be conducted in partnership with a renowned institute from a third country and the return phase to an associated country. The team is well-equipped with the skills and infrastructure required for the project.

The researcher will gain skills that can enhance employability. The project will have societal, technological, and commercial potential as a novel treatment for critical defects.

Topics

Who is involved

OrganisationCityCountryRole
The Royal Veterinary CollegeLondonUnited KingdomCoordinator
Brigham IncBostonUnited StatesAssociatedpartner

Source: CORDIS, European Commission. Data of 5 Nov 2026, reused under the Commission's reuse policy. View on CORDIS · Grant DOI